Jeff Reeves

Jeff Reeves

Jeff Reeves is a financial commentator with almost two decades of newsroom and markets experience, including a stint as an editor for the New York Times Co. He has been lead writer and editor for InvestorPlace.com since the beginning of 2010.  

Jeff’s work has appeared in numerous finance publications and broadcast outlets, including The Wall Street Journal network, CNBC, TheStreet.com, Fox Business Channel, USA Today and a host of others.

View some of his TV appearances on YouTube, or check out his writing links below.

Jeff has also penned an eBook, The Frugal Investor’s Guide to Finding Great Stocks: 11 Free Resources to Help Beginners Identify Fantastic Investments.

Write Jeff at editor@investorplace.com, or follow him on Twitter @JeffReevesIP.

Recent Articles

Growth Story Is Over at Amazon – Sell AMZN Stock ASAP!

By Jeff Reeves

Amazon.com, Inc. has failed to turn its big top line into any bottom line profits, and AMZN stock will continue this painful trend in 2015.

7 Healthcare Stocks Immune to Market Declines

By Jeff Reeves

Thanks to a number of macro tailwinds, these healthcare stocks are great low-risk investments for growth and income investors alike.

Google Stock Will Soar in 2015 – 7 Reasons to Buy GOOG

By Jeff Reeves

Google Inc is one of the biggest names in tech, but its stock has lagged lately. Here's why Google stock will bounce back in 2015.

Home Builders May Be Unlikely Winners in 2015

By Jeff Reeves

Home builders have been unloved by investors, but housing stocks like TOL, PHM and LEN have actually soared lately ... and look good in 2015.

Is Linn Energy Worth the Risk for a 12%-Plus Dividend?

By Jeff Reeves

Linn Energy recently cut its dividend, but LINE stock still yields about 12%. So should you bargain hunt in this battered energy stock?

5 High-Yield MLP Oil Stocks to Buy on a Pullback

By Jeff Reeves

Falling oil prices have spooked investors out of most energy stocks, offering a chance for investors to snag high-yield MLPs at a bargain.

9 Best Cheap Stocks to Buy Now for Under $10

By Jeff Reeves

Some stocks that trade for under $10 have gotten to be cheap for a reason, so the trick is to separate the toxic from those that offer real potential. Here are nine for 2015.

Gilead Sciences is In the Emergency Room – Here’s Why

By Jeff Reeves

Gilead Sciences recently saw its blockbuster hepatitis C drug removed from Express Scripts coverage. That may sink GILD stock for some time.

3 High-Income Oil Stocks Safe from Crude’s Crash

By Jeff Reeves

There are a host of low-risk, long-term plays that should continue to serve investors well regardless of short-term volatility in crude oil prices. Here are three good choices.

7 Biggest Investment Opportunities of 2015

By Jeff Reeves

Here are a host of positive economic developments worth highlighting as we enter 2015, and related investment opportunities worth exploring.

Load More